Case Report
A 26 years old pregnant female (Primigravida and 20 weeks pregnant), doctor by profession presented to us with chief complaints of fever, cough, shortness of breath and chest pain since 5 days at L2 COVID Hospital, Government Medical College, Azamgarh. Fever was high grade, insidious in onset, continuous, no diurnal variation and was relieved on medication. Patient also complained of cough since 5 days. It was dry in nature and was not associated with diurnal or postural variation. She also had shortness of breath since 5 days. It was insidious in onset, mMRC (modified Medical Research Council scale) grade 2 initially but gradually became grade 3. Dyspnea aggravated on exertion and was relieved with rest. She had chest pain since 5 days, which was insidious in onset and dull aching in nature. It was bilateral, non-radiating and non-migratory. No relieving or aggravating factors were present.
No complaints of hemoptysis, loss of weight, loss of appetite, orthopnea, abdominal pain, nausea, vomiting, trauma, altered sensorium or loss of consciousness was there.
No history of tuberculosis/Diabetes Mellitus/Hypertension/Coronary Artery Disease/thyroid disorders/asthma or inhaler use in the past. Patient is non-smoker, non-alcoholic and takes vegetarian diet.
Investigations
At the time of admission
SPO2- 91% at room air.
Blood pressure- 98/66 in right arm supine position.
Respiratory rate- 24 per second.
X-ray chest- PA view (abdominal guarding) - No abnormality was detected.
ABG- showed type 1 respiratory failure.
CBC- Total leukocyte count (TLC) was 5900 (N52 L45 E3) on day of admission.
LFT, RFT, RBS, ECG, Cardiac profile, d-dimer, Serum Ferittin and CRP was normal RTPCR for COVID 19 - positive.
Diagnosis
Based on history, signs, symptoms and investigations, patient was diagnosed to be a case of Primigravida with 20 weeks gestation, COVID -19 positive with moderate severity.
Treatment
Patient was admitted in ward. Moist nasal O2 was given through non-rebreathing mask at 15 litres/minute to maintain target saturation at and above 92%. Nebulisation with budecortesone was done. Antibiotic including ceftriaxone and azithromycin was given. Intravenous fluids were given. Patients blood pressure became normal following fluid infusion. Multivitamins and minerals including vitamin C, D and calcium, iron and folic acid were given. Blood anticoagulant (low molecular weight heparin) was given subcutaneously. Intravenous steroid methylprednisolone was given at 125mg loading dose followed by 80 mg for 5 days and there after tapered to minimum dose by day 15.
On day 3 of admission or day 8th of illness patient’s condition began to deteriorate with respiratory rate 32 per minute. SPO2 falling to 87% with non-rebreathing mask at 15 litres / minute. Patient was immediately shifted to ICU. Investigations were repeated. Chest X-ray PA view showed bilateral patchy infiltration in middle and lower zone. TLC was found to be increased. CRP, d-dimer and serum ferritin were found to be significantly raised indicating worsening of infection.
Inj amoxicillin and Inj clindamycin was started. Also patient was shifted to HFNC (high flow nasal canulla) support at 50 litres/minute and target saturation was maintained at or above 92%. Injection Remdesivir (200 mg loading dose on day 1 followed by 100 mg on day 2-5) and hydroxychloroquinine (loading dose 800 mg in 2 divided doses on day 1 followed by 400 mg daily for day 2-5) was given. Inj N-acetyl cysteine was also started.
Table 1
Following above treatment patient’s condition improved. Investigations were repeated every alternate day which also improvement. SPO2 improved over the period of time and symptoms got better. Repeat RTPCR was negative on day 15 following which patient was discharged with advice of home isolation for 7 days.
Follow-Up
Patient’s follow up was done in non COVID hospital. Obstetric ultrasound was done on 7th day which showed single 23 weeks pregnancy with severe oligohydroamnios (AFI-2.5cm).
In her blood investigations, patient’s random blood sugar was raised and following further investigations she was diagnosed with gestational diabetes mellitus and was put on treatment with insulin.
Patient was kept on weekly follow up. Her ultrasound 15 days later showed moderate oligohyrdramnios (AFI- 6.5) and blood sugars were also within normal range.
Her obstetric ultrasound was repeated every 15 days and her ultrasound at 36 weeks showed AFI- 9.
At 37 weeks of gestation patient spontaneously passed into labour and delivered vaginally an alive, healthy male baby of 2.9kg.
Discussion
Rates of severe coronavirus disease 2019 (COVID-19),1, 2 ICU admission, and maternal mortality increased among pregnant and postpartum women admitted for COVID-19 in the second wave compared with the first wave in India. Pregnancy itself being immunocompromised state, pregnant females were greatly affected by coronavirus with fatal maternal and fetal outcome. In our case, the patient’s symptoms worsened on day 3 of admission and had to be shifted to ICU immediately and aggressive management was started in terms antibiotics (amoxycilin and clindamycin),3 HFNC was started, and antiviral inj Remdesevir was given. Because of timely and aggressive management of the patient with strict monitoring, we were able to save the life of both the mother and fetus.
Conclusion
We observed that the key to management of second wave COVID 19 pandemic is timely and aggressive treatment without delay. Special care needs to be taken for immunocompromised individuals. Pregnant females who were affected with COVID 19 in early stages of pregnancy were observed to develop gestational diabetes mellitus in later stages of pregnancy. Therefore, COVID 19 in second wave not only had immediate